<code id='2E040E9149'></code><style id='2E040E9149'></style>
    • <acronym id='2E040E9149'></acronym>
      <center id='2E040E9149'><center id='2E040E9149'><tfoot id='2E040E9149'></tfoot></center><abbr id='2E040E9149'><dir id='2E040E9149'><tfoot id='2E040E9149'></tfoot><noframes id='2E040E9149'>

    • <optgroup id='2E040E9149'><strike id='2E040E9149'><sup id='2E040E9149'></sup></strike><code id='2E040E9149'></code></optgroup>
        1. <b id='2E040E9149'><label id='2E040E9149'><select id='2E040E9149'><dt id='2E040E9149'><span id='2E040E9149'></span></dt></select></label></b><u id='2E040E9149'></u>
          <i id='2E040E9149'><strike id='2E040E9149'><tt id='2E040E9149'><pre id='2E040E9149'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:485
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          At ASCO, pharma leaders speak of advances in 'smart bomb' drugs
          At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

          ChrisBoshoff,farright,speakingatapanelwith,fromleft,MatthewHerperofSTAT,KenKeller,LeviGarraway,andSu

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          Shifting the focus from loneliness to social health

          AdobeIt’sbeenoneyearsincetheU.S.surgeongeneralissuedanationalwarningaboutanepidemicofloneliness.Othe